Literature DB >> 9705837

Low stimulatory capacity of lymphoid dendritic cells expressing hepatitis C virus genes.

Y Hiasa1, N Horiike, S M Akbar, I Saito, T Miyamura, Y Matsuura, M Onji.   

Abstract

To determine the role of antigen presenting cells (APCs) during hepatitis C virus (HCV) infection, murine lymphoid dendritic cells (LDCs), the most potent APCs, were transfected with HCV genes using adenovirus vector-mediated gene transfer. At a multiplicity of infection (MOI) of 100, more than 90% of the transfected LDCs expressed the HCV genes (encoding core-E2 region). The stimulatory capacity of these LDCs (LDC-AxCA327) in the allogeneic mixed leukocyte reaction (Allo MLR) was significantly lower (P < 0.01) than that of LDCs infected with control adenovirus vector lacking the HCV genes (LDC-Axw1). LDC-AxCA327 also produced significantly lower levels of IL-12 than LDC-Axw1 (P < 0.05). These findings suggest that the inadequate APC capability of LDCs that express HCV genes is related to immunopathology during HCV infection and that IL-12 appears to be involved in this process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705837     DOI: 10.1006/bbrc.1998.9089

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  Mechanisms of immune escape in viral hepatitis.

Authors:  W Rosenberg
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

2.  Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus.

Authors:  N H Gruener; F Lechner; M C Jung; H Diepolder; T Gerlach; G Lauer; B Walker; J Sullivan; R Phillips; G R Pape; P Klenerman
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Repression of interferon regulatory factor 1 by hepatitis C virus core protein results in inhibition of antiviral and immunomodulatory genes.

Authors:  Anna R Ciccaglione; Emilia Stellacci; Cinzia Marcantonio; Valentina Muto; Michele Equestre; Giulia Marsili; Maria Rapicetta; Angela Battistini
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

4.  Robust hepatitis C virus infection in vitro.

Authors:  Jin Zhong; Pablo Gastaminza; Guofeng Cheng; Sharookh Kapadia; Takanobu Kato; Dennis R Burton; Stefan F Wieland; Susan L Uprichard; Takaji Wakita; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

5.  Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection.

Authors:  F S Wang; L H Xing; M X Liu; C L Zhu; H G Liu; H F Wang; Z Y Lei
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

6.  HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C.

Authors:  Rainer P Woitas; Uwe Petersen; Dirk Moshage; Hans H Brackmann; Bertfried Matz; Tilman Sauerbruch; Ulrich Spengler
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

7.  Dendritic cell function is perturbed by Yersinia enterocolitica infection in vitro.

Authors:  M Schoppet; A Bubert; H I Huppertz
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

8.  Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins.

Authors:  Pablo Sarobe; Juan José Lasarte; Noelia Casares; Ascensión López-Díaz de Cerio; Elena Baixeras; Pablo Labarga; Nicolás García; Francisco Borrás-Cuesta; Jesús Prieto
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

9.  Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses.

Authors:  Pablo Sarobe; Juan José Lasarte; Aintzane Zabaleta; Laura Arribillaga; Ainhoa Arina; Ignacio Melero; Francisco Borrás-Cuesta; Jesús Prieto
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  High serum palmitic acid is associated with low antiviral effects of interferon-based therapy for hepatitis C virus.

Authors:  Teruki Miyake; Yoichi Hiasa; Masashi Hirooka; Yoshio Tokumoto; Takao Watanabe; Shinya Furukawa; Teruhisa Ueda; Shin Yamamoto; Teru Kumagi; Hiroaki Miyaoka; Masanori Abe; Bunzo Matsuura; Morikazu Onji
Journal:  Lipids       Date:  2012-09-16       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.